Lazard Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Lazard Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,171	Closed	-$211K	–	1224
2018 Q4	$211K	Buy	+2,171	New	+$285K	﹤0.01%	861
2015 Q4	–	Sell	-1,515	Closed	-$138K	–	1165
2015 Q3	$138K	Buy	1,515 +515	+52%	+$57.3K	﹤0.01%	829
2015 Q2	$122K	Buy	+1,000	New	+$113K	﹤0.01%	896

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lazard Asset Management's GWPH Position: Q1 2019 in Review

Lazard Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 2,171 shares — an estimated $211K sold.

Lazard Asset Management first reported a position in GWPH in Q2 2015 and held it in 3 quarters. The position peaked at $211K in Q4 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

Lazard Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Lazard Asset Management sold 2,171 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $211K.
Lazard Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and held it in 3 quarters.
Lazard Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $211K in Q4 2018.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Lazard Asset Management's 13F filing for Q1 2019, filed 13 May 2019.